bsm, yes, Roslin would have a "bank" of cells that can be purchased for research or commercialization. If commercialized then "Commercialization licenses will also provide access to the cell lines biologics master file in order to establish regulatory compliance. If set up the way the PR describes these cell lines would be ready to go straight from the lab into clinical trials. Remember also that currently no FED funding would be available using these cell lines although it does remove the ethical issue for some institutions.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.